[A case of primary malignant fibrous histiocytoma of the stomach].
Explore the source record for details and available documents.
Biomedical subjects
Publications and source records attributed to S Okada.
Explore the source record for details and available documents.
In chemotherapy (CHT) for solid tumors, improvement of symptoms may be clinically beneficial, even if objective tumor responses are not recognized. The vast majority of patients with advanced pancreatic cancer (PC) are symptomatic at diagnosis. In particular, severe pain and poor general condition can be major debilitating problems. In patients with such symptoms, optimal palliation of symptoms to maximization the quality of life is of primary importance. In recent years, such a clinical benefit response (CBR) has become a new treatment end-point being explored in clinical trials involving PC. The CBR is generally evaluated using two parameters in patients with PC: pain (intensity of pain and consumption of morphine) and Karnofsky performance status (KPS). A remarkable CBR was obtained in about 20-25% of patients treated with gemcitabine or combined CHT using fluorouracil and cisplatin (FP therapy). This new assessment method for CHT using CBR may be useful for evaluating chemotherapeutic response and may provide a strong rationale for continuing CHT in patients with stable disease according to imaging modalities.
With understanding the biochemical and molecular characteristics of mitochondrial disorders, several point mutations or deficient of mitochondrial DNA have been identified in patients with mitochondrial dysfunction. The clinical manifestations of this disorders are heterogeneous and most patients show abnormality of the central nervous system, skeletal muscle, heart, kidney or these combinations. Especially, cardiac involvement is very important because it is determinant factor for the prognosis. There are two types of cardiac manifestation; cardiomyopathy and cardiac conduction defects. The former is usually hypertrophic, but dilated forms have been demonstrated. The latter is well known as one of three main symptoms in Kearn-Sayre syndrome. We discuss the pathogenesis, pathology and clinical manifestation of mitochondrial cardiomyopathy.
We retrospectively studied 26 patients with stenotic lesions of the central airway who had undergone bronchoscopic treatment. Thirteen of the patients had malignant tumors, and 13 had benign lesions (1 with post-tracheostomy difficulty in tube retrieval, 2 with bronchial obstruction due to granulation after bronchoplasty, 1 with bronchial stenosis due to granulation after pulmonary lobectomy, 7 with endobronchial foreign bodies, and 2 with hemoptysis). The patients ranged from 5 to 88 years of age with an average of 59.7 years. As a rule, bronchoscopic treatment was performed with endotracheal intubation up to 1993, and with laryngeal mask placement in 1994 and thereafter. Of the 26 eligible patients, 24 (92%) experienced good or excellent outcomes. Emergency bronchoscopy may be useful in treating a variety of emergency airway conditions. Use of a laryngeal mask may benefit emergency patients, including infants and children requiring a secure airway without complications.
The bacteria isolated from the patients with lower respiratory tract infections were collected by institutions located throughout Japan, since 1981. Ikemoto et al. have been investigating susceptibilities of these isolates to various antibacterial agents and antibiotics, and analyzed some characteristics of the patients and isolates from them each year. Results obtained from these investigations are discussed. In these 18 institutions around the entire Japan, 532 strains of presumably etiological bacteria were isolated mainly from the sputa of 438 patients with lower respiratory tract infections during the period from October in 1998 to September in 1999. MICs of various antibacterial agents and antibiotics were determined against 85 strains of Staphylococcus aureus, 100 strains of Streptococcus pneumoniae, 96 strains of Haemophilus influenzae, 75 strains of Pseudomonas aeruginosa (non-mucoid strains), 6 strains of Pseudomonas aeruginosa (mucoid strains), 38 strains of Moraxella subgenus Branhamella catarrhalis, 26 strains of Klebsiella pneumoniae etc., and the susceptibilities of 517 strains were assessed except for those strains that died during transportation. S. aureus strains for which MICs of oxacillin (MPIPC) were higher than 4 micrograms/ml (methicillin-resistant S. aureus: MRSA) accounted for 60.0%. Vancomycin (VCM) and arbekacin (ABK) showed the most potent activities against MRSA. But one of MRSA showed resistance to ABK with the MIC of 64 micrograms/ml. The sensitive strains of MRSA to VCM have decreased. The frequency of penicillin (PC)-intermediate S. pneumoniae (PISP) + PC-resistant S. pneumoniae (PRSP) have increased in 46.0% for 1998 comparatively from 30.9% of 1997's. But PRSP decreased, and PISP increased into 39.0% of 1998 years from 19.8% of 1997's. Panipenem (PAPM), imipenem (IPM) and faropenem (FRPM) showed the most potent activities against S. pneumoniae with MIC80s of 0.125 microgram/ml or below. Against H. influenzae and M. (B.) catarrhalis, almost all the drugs showed good activities. The sensitive strains of them against ceftazidime (CAZ) decreased in 1997, but those have increased in 1998. Inversely, the susceptibility of them against cefotiam (CTM) had been higher in 1997, but those have been lower in 1998. Tobramycin (TOB) showed the most potent activity against P. aeruginosa (both mucoid and nonmucoid strains). All drugs except ampicillin (ABPC) were active against K. pneumoniae. A quite few of K. pneumoniae showed low susceptibilities. Also, we investigated year to year changes in the characteristics of patients, their respiratory infectious diseases, and the etiology. The examination of age distribution indicated that the proportion of patients with ages over 70 years was 48.6% of all the patients showing a slight increase in every year. About the proportion of diagnosed diseases as follows: Bacterial pneumonia was the most frequent with 40.2%. The ratio of it has increased slightly, and the increased rate was 10% in patients with ages over 70 years compared with the results in 1997. Chronic bronchitis have decreased slightly with 27.6% in 1998. Number of strains isolated from patients before administration of antibiotics were more than those after administration of them in chronic bronchitis, but these were almost same number in bacterial pneumonia. Administration of antibiotics has changed the results of the frequency of isolation of bacterial species. Bacterial isolations before administration of antibiotics were as follows: S. pneumoniae 26.7%, H. influenzae 23.8%, S. aureus 13.3% and M. (B.) catarrhalis 10.8%. The frequencies of S. aureus decreased after antibiotics administration over 15 days, but the frequencies of P. aeruginosa (both mucoid and non-mucoid) was not affected. The frequencies of P. aeruginosa was 45.5% after administration over 15 days. The frequencies of S. pneumoniae decreased upon administration of antibiotics, these were only 4.5% over 15 days. The frequencies of H. (
We report a case of thoracoscopic major lung resection using a newly-developed instrument retraction system and a voice-controlled robot for lung cancer in a 72-year-old woman. The patient was referred to our department for further examination of an abnormal shadow on chest x-ray. A chest computed tomographic scan indicated a suspicion of malignancy. Bronchoscopic brush cytology revealed a lung cancer. Thoracoscopic middle lobectomy of the right lung with dissection of the mediastinal lymphnodes was successfully performed without a human assistance with no complications. The postoperative course was uneventful. Thoracoscopic major lung resection using an instrument retraction system and a voice-controlled robot may be feasible in selected cases.
Explore the source record for details and available documents.
A 40-year-old man was admitted to our hospital with acute respiratory failure. The patient was given a diagnosis of Pneumocystis carinii pneumonia (PCP) associated with acquired immunodeficiency syndrome (AIDS). After treatment with trimethoprim-sulfamethoxazole and corticosteroid, the respiratory failure was improved and the abnormal shadows disappeared. The serum beta-D-glucan level, significantly elevated (76.0 pg/ml) on admission, returned to the normal range within two weeks. Serum KL-6 (max. 7580 U/ml) and surfactant protein-D (SP-D) (max. 235 ng/ml), which are produced by type II pneumocytes, increased after elevation of the beta-D-glucan level and decreased gradually following successful treatment. These findings suggest that beta-D-glucan may be a serological marker for PCP infection and KL-6 may be a serological marker for lung injury in PCP with AIDS.
AIM: The aim of this study is to clarify the age-related characteristics of pediatric IgA nephropathy. PATIENTS AND METHODS: Five cases in preschool children less than 6 years old were analyzed and compared to 38 cases in older children from 6 to 15 years old. RESULTS: The group of younger children had higher incidences of gross hematuria, hypertension, proteinuria, and hypoproteinemia. Renal biopsy specimens in this group showed more intracapillary lesions including mesangial cell proliferation and endocapillary proliferation ofglomeruli, but less segmental lesions, global sclerosis, and interstitial changes. CONCLUSION: IgA nephritis in preschool children demonstrated more symptoms of acute onset and less chronic renal injury.
Explore the source record for details and available documents.
The raw material of thiamine hydrochloride solution was examined for preparation of the "Thiamine Hydrochloride Solution Reference Standard (Control 991)". The analytical data obtained were: assay by HPLC, 101.0%; spectrophotometric assay, 100.4%. Based on the above results, the raw material was authorized as the Thiamine Hydrochloride Solution Reference Standard (Control 991) of the National Institute of Health Sciences.
The raw material of tocopherol acetate was examined for the preparation of the "Tocopherol Acetate Reference Standard (Control 001)". Analytical data obtained were: IR spectrum, same as that of the Tocopherol Acetate Reference Standard (Control 974); specific absorbance, E/cm% (284 nm) = 43.7; thin-layer chromatography, no impurities were detected until 50 micrograms of the loaded raw material; high-performance liquid chromatography (HPLC), total amount of impurities estimated to be less than 0.6%; assay by HPLC, 101.7%. Based on the above results, the raw material was authorized as the Japanese Pharmacopoeia Reference Standard (Control 001).
The raw material of tocopherol was tested for the preparation of "Tocopherol Reference Standard (Control 991)". Analytical data obtained were: IR spectrum, same as the Tocopherol Reference Standard (Control 941); specific absorbance, E/cm% (292 nm) = 72.9; thin-layer chromatography, no impurities were detected until 50.0 micrograms; high-performance liquid chromatography (HPLC), trace amounts of five impurities were detected and the total amount was estimated to be less than 1.4%; assay by HPLC, 99.9%. Based on the above results, the raw material was authorized as the Japanese Pharmacopoeia Standard (Control 991).
The raw material for prednisolone sodium phosphate was examined for the preparation of the "Prednisolone Sodium Phosphate Reference Standard (Control 001)". The analytical data obtained were: pH, 7.9; optical rotation, [alpha]D20 = +98.0 degrees; UV spectrum, lambda max of 248 nm and specific absorbance in ethanol at 248 nm = 306.7; IR spectrum, same as that of the Prednisolone Sodium Phosphate Reference Standard (Control 892); thin-layer chromatography, five impurities were detected at 200 micrograms; high-performance liquid chromatography (HPLC), total amount of impurities estimated to be less than 3.7%; residual solvent, 0.0% (ethanol) and 0.0% (hexane); loss on drying, 2.7%. Based on the above results, the raw material was authorized as the Prednisolone Sodium Phosphate Reference Standard (Control 001) of the National Institute of Health Sciences.
The raw material of tocopherol was tested for the preparation of "Estradiol Reference Standard (Control 991)". Analytical data obtained were: melting point, 178.5 degrees C: UV spectrum, lambda max of 281 nm and specific absorbance in ethanol at lambda max = 77.7; IR spectrum, same as that of the Estradiol Reference Standard (Control 964); optical rotation, [alpha]D20 = +79.5 degrees; thin-layer chromatography, one impurity was detected; high-performance liquid chromatography (HPLC), total amount of impurities estimated to be less than 0.6%; loss on drying, 3.3%; assay, 100.2% by UV spectrophotometry and 99.9% by HPLC. Based on the above results, the raw material was authorized as the Estradiol Reference Standard (Control 001) of the National Institute of Health Sciences.
The National Institute of Health Sciences Reference Standard for Heparin Sodium (Control 991) was prepared. The potency of heparin sodium for the candidate reference standard was assayed against "Heparin Sodium Reference Standard (Control 871)" by JP Method in collaboration with 4 laboratories, and estimated as 1,453 +/- 25 units per ampoule. The filling amounts of heparin sodium in ampoule was estimated as 7.46 +/- 0.15 mg per ampoule, and the precision of filling into ampoule was about 2.0% as C.V. Based on the above results, the candidate was defined as 1450 units per ampoule, and was authorized as the Heparin Sodium Reference Standard (Control 991) of the National Institute of Health Sciences.
The role of cellular immunity in vaccine protection against FIV infection was evaluated using adoptive cell transfer studies. Specific-pathogen-free cats received two adoptive transfers of washed blood cells from either vaccinated or unvaccinated donors with varying MHC compatibility at 1-week intervals, and a homologous FIV(Pet) challenge 1 day after the first adoptive transfer. FIV-specific CTL, IFN-gamma production, and proliferation responses were detected in the PBMC from the vaccinated donors. Seven of eleven (64%) recipients of cells from half-matched/vaccinated donors remained negative for FIV-antibodies after FIV challenge and four of those were completely protected. Two of two recipients of cells from MHC-identical/vaccinated donors were completely protected. All recipients of cells from unrelated/vaccinated, half-matched/unvaccinated, or unrelated/unvaccinated donors were unprotected. Thus, protection mediated by adoptive transfer of immunocytes from vaccinated cats was MHC-restricted, occurred in the absence of antiviral humoral immunity, and correlated with the transfer of cells with FIV-specific CTL and T-helper activities.
The localization of human vitamin D receptor (VDR) in the absence of its ligand 1,25-dihydroxyvitamin D(3) was investigated using chimera proteins fused to green fluorescent protein (GFP) at either the N or C terminus, and the nuclear localization signal (NLS) was identified. Plasmids carrying the fusion proteins were transiently or stably introduced into COS7 cells, and the subcellular distribution of the fusion proteins was examined. GFP-tagged wild-type VDRs were located predominantly in nuclei but with a significant cytoplasmic presence, while GFP alone was equally distributed throughout the cells. 10(-8) M 1,25-dihydroxyvitamin D(3) promoted the nuclear import of VDR in a few hours. To identify the NLS, we constructed several mutated VDRs fused to GFP. Mutant VDRs that did not bind to DNA were also localized predominantly in nuclei, while the deletion of the hinge region resulted in the loss of preference for nucleus. A short segment of 20 amino acids in the hinge region enabled cytoplasmic GFP-tagged alkaline phosphatase to translocate to nuclei. These results indicate that 1) VDR is located predominantly in nuclei with a significant presence in cytoplasm without the ligand and 2) an NLS consisting of 20 amino acids in the hinge region facilitates the transfer of VDR to the nucleus.